|
Suvaxyn Circo+MH RTU
|
-
|
EU/2/15/190/001
|
Zoetis Belgium S.A., Beļģija
|
QI09AL
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Inactivated Mycoplasma hyopneumoniae,Inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2 ORF2 protein
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Zoetis Belgium S.A., Beļģija
|
| Date of authorisation/renewal: |
16-Sep-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/15/190/001 |
|
1 |
Polietilēna flakons, 25 deva |
-
|
|
|
Cepedex
|
0.5 mg/ml
|
EU/2/16/200/005
|
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
QN05CM18
|
dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Dexmedetomidine hydrochloride
|
| Distribution category: |
To be used only by veterinary surgeon
|
| Manufacturer(s) responsible for batch release |
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
| Date of authorisation/renewal: |
11-Nov-2021
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/16/200/005 |
0,5 mg/ml |
1 |
Stikla flakons, 10 ml |
[PDF]
[PDF]
|
|
|
NEWFLEND ND H9
|
-
|
EU/2/23/296/002
|
Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
|
QI01AD
|
chickens; embryonated chicken eggs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
concentrate and solvent for suspension for injection
|
| International name (active substance): |
Turkey herpes virus, strain rHVT/ND expressing Newcastle disease virus, Live
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
16-May-2023
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/23/296/002 |
|
1 |
Stikla ampula, 2000 devas/flakonā |
-
|
|
|
Semintra
|
4 mg/ml
|
EU/2/12/146/002
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QC09CA07
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for oral use
|
| International name (active substance): |
Telmisartan
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Boehringer Ingelheim Pharma GmbH & Co. KG, Vācija
|
| Date of authorisation/renewal: |
13-Feb-2013
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/12/146/002 |
4 mg |
1 |
ABPE pudelīte, 100 ml |
-
|
|
|
Equisolon
|
33 mg/g
|
EU/2/14/161/004
|
Le Vet B.V., Nīderlande
|
QH02AB06
|
horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
oral powder
|
| International name (active substance): |
Prednisolone
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Lelypharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
14-Mar-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/14/161/004 |
33 mg/g |
1 |
Pudelīte, 504 g |
-
|
|
|
Metacam
|
5 mg/ml
|
EU/2/97/004/010
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QM01AC06
|
cattle; pigs; horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Labiana Life Sciences S.A., Spānija
|
| Date of authorisation/renewal: |
06-Dec-2007
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/97/004/010 |
5 mg/ml |
12 |
Stikla flakons, 100 ml |
-
|
|
|
Sedadex
|
0.5 mg/ml
|
EU/2/16/198/002
|
Le Vet Beheer B.V., Nīderlande
|
QN05CM18
|
dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Dexmedetomidine hydrochloride
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Produlab Pharma b.v., Nīderlande
|
| Date of authorisation/renewal: |
18-Aug-2021
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/16/198/002 |
0,5 mg/ml |
1 |
Stikla flakons, 10 ml |
-
|
|
|
Stronghold
|
120 mg
|
EU/2/99/014/005
|
Zoetis Belgium S.A., Beļģija
|
QP54AA05
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Selamectin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Pfizer Service Company bvba, Beļģija
|
| Date of authorisation/renewal: |
01-Oct-2009
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/99/014/005 |
120 mg/deva |
3 |
Polipropilēna tūbiņa, 1 deva |
-
|
|
|
Prac-tic
|
56.25 mg
|
EU/2/06/066/003
|
Elanco GmbH, Vācija
|
QP53AX26
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Pyriprole
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
Elanco France S.A.S, Francija
|
| Date of authorisation/renewal: |
16-Nov-2011
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/06/066/003 |
56,25 mg/deva |
30 |
Pipete, 1 deva |
-
|
|
|
Credelio
|
450 mg
|
EU/2/17/206/011
|
Elanco GmbH, Vācija
|
QP53BE04
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Lotilaner
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Elanco France S.A.S, Francija
|
| Date of authorisation/renewal: |
26-Apr-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/17/206/011 |
450 mg |
3 |
Alumīnija blisteris, 3 tablete |
-
|
|
|
Coxatab
|
100 mg
|
EU/2/22/286/014
|
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
QM01AH90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
Chewable tablet
|
| International name (active substance): |
Firocoxib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
| Date of authorisation/renewal: |
12-Aug-2022
|
| Marketing authorisation valid until: |
11-Aug-2027
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/22/286/014 |
100 mg/tabl. |
1 |
alumīnija/PVC/PE/PVDC blisteris, 10 mg/tabl. |
-
|
|
|
Loxicom
|
5 mg/ml
|
EU/2/08/090/006
|
Norbrook Laboratories (Ireland) Limited, Īrija
|
QM01AC06
|
dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Norbrook Laboratories Limited, Lielbritānija
|
| Date of authorisation/renewal: |
12-Mar-2014
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/08/090/006 |
5 mg/ml |
1 |
Stikla flakons, 10 ml |
-
|
|
|
Rheumocam
|
1 mg
|
EU/2/07/078/005
|
Chanelle Pharmaceuticals Manufacturing Limited, Īrija
|
QM01AC06
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
|
| Date of authorisation/renewal: |
18-Dec-2012
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/07/078/005 |
1 mg/tabl. |
20 |
PVH/PVDH blisteris, 1 tablete |
-
|
|
|
Metacam
|
40 mg/ml
|
EU/2/97/004/053
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QM01AC06
|
cattle; horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Produlab Pharma b.v., Nīderlande
|
| Date of authorisation/renewal: |
20-May-2015
|
| Marketing authorisation valid until: |
19-May-2020
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/97/004/053 |
40 mg/ml |
12 |
Stikla flakons, 100 ml |
-
|
|
|
VAXXON ND CLONE
|
-
|
EU/2/24/326/004
|
Izo S.r.l., Itālija
|
QI01AD06
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for oculonasal suspension
|
| International name (active substance): |
Live Newcastle Disease virus, strain Clone 30
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
22-Nov-2024
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/24/326/004 |
|
10 |
I tipa stikla flakons, 2500 deva |
-
|
|
|
FRONTPRO
|
11.3 mg
|
EU/2/19/240/001
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QP53BE01
|
Dogs 2–4 kg
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Afoxolaner
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
Merial, Francija
|
| Date of authorisation/renewal: |
20-May-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/19/240/001 |
11,3 mg |
1 |
PVH/Aclar/Al blisteris, 1 tablete |
-
|
|
|
Lineomam LC
|
-
|
V/I/19/0074
|
Bioveta, a.s., Čehija
|
QJ51RF03
|
cattle (lactating cows)
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
intramammary solution
|
| International name (active substance): |
Lincomycin hydrohloride, Neomycin sulphate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Bioveta, a.s., Čehija
|
| Date of authorisation/renewal: |
04-Dec-2024
|
| Marketing authorisation valid until: |
03-Dec-2029
|
| Marketing authorisation procedure: |
I
|
| Package leaflet: |
[DOCX] 04122024_LI (04-Dec-2024)
|
| Labelling text: |
See products section
|
| Summary of product characteristics: |
-
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/I/19/0074-01 |
|
24 |
Injektors, 10 ml |
[PDF]
[PDF]
|
|
|
Porcilis PCV
|
-
|
EU/2/08/091/007
|
Intervet International B.V., Nīderlande
|
QI09AA07
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Inactivated recombinant Porcine Circovirus type 2
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet International B.V., Nīderlande
|
| Date of authorisation/renewal: |
14-Jan-2014
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/08/091/007 |
|
10 |
Pudelīte, 50 ml |
-
|
|
|
Rheumocam
|
5.0 mg/ml
|
EU/2/07/078/020
|
Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
|
QM01AC06
|
cattle; pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
|
| Date of authorisation/renewal: |
18-Dec-2012
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/07/078/020 |
5 mg/ml |
1 |
Stikla flakons, 100 ml |
-
|
|
|
Felpreva
|
-
|
EU/2/21/277/008
|
Vetoquinol S.A., Francija
|
QP52AA51
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Tigolaner, Emodepside, Praziquantel
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Vetoquinol S.A., Francija
|
| Date of authorisation/renewal: |
11-Nov-2021
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/21/277/008 |
|
20 |
Polipropilēna aplikators, 0,74 ml |
-
|
|